Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Thermo Fisher Scientific
(NY:
TMO
)
514.23
+18.12 (+3.65%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Thermo Fisher Scientific
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
32
33
Next >
Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely
↗
October 11, 2022
One analyst doubts any deal could come to fruition. If it did, it would make sense.
Via
Investor's Business Daily
Bio-Rad Laboratories, Qiagen Mull Merger Of Equals
↗
October 11, 2022
Bio-Rad Laboratories Inc (NYSE: BIO) is reportedly in talks to merge with Qiagen NV (NYSE: QGEN), but any agreement isn't likely for another few weeks or more, or it may not happen at all.
Via
Benzinga
7 Value Stocks That Are Too Cheap to Ignore
↗
October 09, 2022
With market and economic forces eschewing growth-focused companies, now may be the time to consider cheap value stocks to buy.
Via
InvestorPlace
Check Out What Whales Are Doing With TMO
↗
October 04, 2022
Someone with a lot of money to spend has taken a bearish stance on Thermo Fisher Scientific (NYSE:TMO). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 26, 2022
October 04, 2022
From
Thermo Fisher Scientific Inc.
Via
Business Wire
Thermo Fisher Invests $160M to Expand Bioproduction Capacity
↗
September 20, 2022
Via
Benzinga
Expert Ratings for Thermo Fisher Scientific
↗
September 12, 2022
Analysts have provided the following ratings for Thermo Fisher Scientific (NYSE:TMO) within the last quarter:
Via
Benzinga
Where Thermo Fisher Scientific Stands With Analysts
↗
August 25, 2022
Thermo Fisher Scientific (NYSE:TMO) has observed the following analyst ratings within the last quarter:
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
September 29, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Thermo Fisher Scientific to Source Half of its U.S. Electricity Needs from Wind Power Purchase with Enel North America
September 29, 2022
From
Thermo Fisher Scientific Inc.
Via
Business Wire
Thermo Fisher's Oncomine Dx Test Is First FDA Approved NGS-Based Companion Diagnostic To Detect Thyroid Cancers
↗
September 28, 2022
Via
Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
↗
September 27, 2022
Via
Benzinga
Can Healthcare Stocks Continue To Outperform?
↗
September 26, 2022
Large-cap healthcare and biotech stocks have been resilient amidst the market turmoil caused by rising rates and the global geopolitical crisis.
Via
Talk Markets
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
↗
September 23, 2022
The World Health Organization (WHO) warned that it struggles to identify and
Via
Benzinga
HC Wainwright Cuts Price Target On This Stock By 73%, Also Check Out Other Major PT Changes Here
↗
September 12, 2022
Susquehanna cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $195. Susquehanna analyst Shyam Patil maintained the stock with a Positive rating. Baidu shares rose 0.7% to $139.38 in...
Via
Benzinga
Trump Ally Dr. Oz Hyped Unapproved 'Covid Cures' From Companies He Owns Shares Of
↗
September 08, 2022
Republican Pennsylvania Senate candidate Dr. Mehmet Oz owns shares of two companies he publicly supported, touting their drugs as potential Covid-19 treatments — even though the drugs weren't approved...
Via
Benzinga
Thermo Fisher Scientific to Present at Morgan Stanley 2022 Global Healthcare Conference
September 07, 2022
From
Thermo Fisher Scientific Inc.
Via
Business Wire
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,000 Today
↗
September 02, 2022
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 15 years by 9.91% on an annualized basis producing an average annual return of 16.88%. Currently, Thermo Fisher Scientific...
Via
Benzinga
Check Out What Whales Are Doing With TMO
↗
September 01, 2022
Someone with a lot of money to spend has taken a bearish stance on Thermo Fisher Scientific (NYSE:TMO). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
No More Free COVID-19 At-Home Tests, Federal Government Says
↗
August 29, 2022
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au
Via
Benzinga
Expert Ratings for Thermo Fisher Scientific
↗
August 25, 2022
Over the past 3 months, 5 analysts have published their opinion on Thermo Fisher Scientific (NYSE:TMO) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
What 5 Analyst Ratings Have To Say About Thermo Fisher Scientific
↗
August 25, 2022
Thermo Fisher Scientific (NYSE:TMO) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
↗
August 25, 2022
Upgrades
Via
Benzinga
The 7 Safest Blue-Chip Dividend Stocks to Buy for the Rest of 2022
↗
August 23, 2022
Investors are wise to consider the safest blue-chip dividend stocks as this year's volatility may only be getting started.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
↗
August 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Agilent Puts Together Commanding Beat That Ignores Messy Medtech Dynamics
↗
August 17, 2022
Agilent managed to stave off challenges due to Covid and exchange rates for a big beat.
Via
Investor's Business Daily
The 3 Best Vanguard Funds to Buy in August
↗
August 08, 2022
VCR, VHT and VYM are among the best Vanguard funds to buy now. Here is why they will make great investments in the coming months.
Via
InvestorPlace
Check Out What Whales Are Doing With Thermo Fisher Scientific
↗
August 08, 2022
Someone with a lot of money to spend has taken a bearish stance on Thermo Fisher Scientific (NYSE:TMO). And retail traders should know. We noticed this today when the big position showed up on...
Via
Benzinga
Earnings Continue to Win
↗
August 04, 2022
In today’s Market360, we are going to look at three companies’ earnings that were recently upgraded in Portfolio Grader and see whether it’s time to buy.
Via
InvestorPlace
Here's How Much $1000 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today
↗
August 04, 2022
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 20 years by 11.6% on an annualized basis producing an average annual return of 19.59%. Currently, Thermo Fisher Scientific...
Via
Benzinga
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.